#Cigna - Wealtoro

#Cigna

2 articles tagged

Markets•6 days ago

Cigna Stock Falls Despite Strong Q3 Revenue Growth

Cigna's stock fell over 17% despite reporting a 10% rise in Q3 revenue. Investor concern is focused on future profit pressure from new contracts and a shift to a rebate-free drug model.

By Priya Sharma

#Cigna#Healthcare#Stock Market

Business•Oct 27

Cigna to End Drug Rebates in Major Policy Shift

Insurance giant Cigna Group has announced it will eliminate prescription drug rebates in many commercial health plans starting in 2027, a move that could reshape U.S. drug pricing.

By David Chen

#Cigna#Healthcare#Insurance

Related Tags

Cigna Stock Falls Despite Strong Q3 Revenue Growth

Cigna to End Drug Rebates in Major Policy Shift

Newsletter

Newsletter